MOTHER'S DAY SPECIALS! SHOW ME MORE

Close Notification

Your cart does not contain any items

Single-Arm Phase II Survival Trial Design

Jianrong Wu

$101

Paperback

Not in-store but you can order this
How long will it take?

QTY:

English
Chapman & Hall/CRC
24 July 2023
Single-Arm Phase II Survival Trial Design provides a comprehensive summary to the most commonly- used methods for single-arm phase II trial design with time-to-event endpoints. Single-arm phase II trials are a key component for successfully developing advanced cancer drugs and treatments, particular for target therapy and immunotherapy in which time-to-event endpoints are often the primary endpoints. Most test statistics for single-arm phase II trial design with time-to-event endpoints are not available in commercial software.

Key Features:

Covers the most frequently used methods for single-arm phase II trial design with time-to-event endpoints in a comprehensive fashion.

Provides new material on phase II immunotherapy trial design and phase II trial design with TTP ratio endpoint.

Illustrates trial designs by real clinical trial examples

Includes R code for all methods proposed in the book, enabling straightforward sample size calculation.
By:  
Imprint:   Chapman & Hall/CRC
Country of Publication:   United Kingdom
Dimensions:   Height: 234mm,  Width: 156mm, 
Weight:   453g
ISBN:   9780367653491
ISBN 10:   0367653494
Series:   Chapman & Hall/CRC Biostatistics Series
Pages:   263
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Paperback
Publisher's Status:   Active

Jianrong (John) Wu is a professor in the Division of Cancer Biostatistics, Department of Internal Medicine, University of Kentucky; Biostatistics and Bioinformatics Shared Resource, Markey Cancer Center. Dr. Wu has more than 20 years’ experience of designing and conducting cancer clinical trials at St. Jude Children’s Research Hospital and Markey Cancer Center and has developed many novel statistical methods for designing and monitoring single-arm phase II and randomized phase III trial design with time-to-event endpoints.

Reviews for Single-Arm Phase II Survival Trial Design

""I would say it is a great book, great summary of not so common and widely available methods, focusing for a statistical audience with strong statistical skills."" David Manteigas, Portugal, ISCB News, June 2022.


See Also